AND
-
KAIST to Collaborate with AT&C to Take Dominance over Dementia
< Photo 1. (From left) KAIST Dean of the College of Natural Sciences Daesoo Kim, KAIST President Kwang Hyung Lee, AT&C Chairman Ki Tae Lee, AT&C CEO Jong-won Lee >
KAIST (President Kwang Hyung Lee) announced on January 9th that it signed a memorandum of understanding for a comprehensive mutual cooperation with AT&C (CEO Jong-won Lee) at its Seoul Dogok Campus to expand research investment and industry-academia cooperation in preparation for the future cutting-edge digital bio era.
Senile dementia is a rapidly increasing brain disease that affects 10% of the elderly population aged 65 and older, and approximately 38% of those aged 85 and older suffer from dementia. Alzheimer's disease is the most common dementia in the elderly and its prevalence has been increasing rapidly in the population of over 40 years of age. However, an effective treatment is yet to be found.
The Korean government is investing a total of KRW 1.1 trillion in dementia R&D projects from 2020 to 2029, with the goal of reducing the rate of increase of dementia patients by 50%. Since it takes a lot of time and money to develop effective and affordable medicinal dementia treatments, it is urgent to work on the development of digital treatments for dementia that can be applied more quickly.
AT&C, a digital healthcare company, has already received approval from the Ministry of Food and Drug Safety (MFDS) for its device for antidepressant treatment based on transcranial magnetic stimulation (TMS) using magnetic fields and is selling it domestically and internationally. In addition, it has developed the first Alzheimer's dementia treatment device in Korea and received MFDS approval for clinical trials. After passing phase 1 to evaluate safety and phase 2 to test efficacy on some patients, it is currently conducting phase 3 clinical trials to test efficacy on a larger group of patients.
This dementia treatment device is equipped with a system that combines non-invasive electronic stimulations (TMS electromagnetic stimulator) and digital therapeutic prescription (cognitive learning programs) to provide precise, automated treatment by applying AI image analysis and robotics technology.
Through this agreement, KAIST and AT&C have agreed to cooperate with each other in the development of innovative digital treatment equipment for brain diseases. Through research collaboration with KAIST, AT&C will be able to develop technology that can be widely applied to Parkinson's disease, stroke, mild cognitive impairment, sleep disorders, etc., and will develop portable equipment that can improve brain function and prevent dementia at home by utilizing KAIST's wearable technology.
To this end, AT&C plans to establish a digital healthcare research center at KAIST by supporting research personnel and research expenses worth approximately 3 billion won with the goal of developing cutting-edge digital equipment within 3 years.
The digital equipment market is expected to grow at a compounded annual growth rate of 22.1% from 2023 to 2033, reaching a market size of $1.9209 trillion by 2033.
< Photo 2. (From left) Dean of the KAIST College of Natural Sciences Daesoo Kim, Professor Young-joon Lee, Professor Minee Choi of the KAIST Department of Brain and Cognitive Sciences, KAIST President Kwang Hyung Lee, Chairman Ki Tae Lee, CEO Jong-won Lee, and Headquarters Director Ki-yong Na of AT&C >
CEO Jong-won Lee said, “AT&C is playing a leading role in the treatment of Alzheimer’s disease using TMS (transcranial magnetic stimulation) technology. Through this agreement with KAIST, we will do our best to create a new paradigm for brain disease treatment and become a platform company that can lead future medical devices and medical technology.”
Former Samsung Electronics Vice Chairman Ki Tae Lee, a strong supporter of this R&D project, said, “Through this agreement with KAIST, we plan to prepare for a new future by combining the technologies AT&C has developed so far with KAIST’s innovative and differentiated technologies.”
KAIST President Kwang Hyung Lee emphasized, “Through this collaboration, KAIST expects to build a world-class digital therapeutics infrastructure for treating brain diseases and contribute greatly to further strengthening Korea’s competitiveness in the biomedical field.”
The signing ceremony was attended by KAIST President Kwang Hyung Lee, the Dean of KAIST College of Natural Sciences Daesoo Kim, AT&C CEO Lee Jong-won, and the current Chairman of AT&C, Ki Tae Lee, former Vice Chairman of Samsung Electronics.
2025.01.09 View 3464 -
KAIST Opens Newly Expanded Center for Contemplative Research in Collaboration with Brain and Cognitive Sciences Department
KAIST (represented by President Kwang Hyung Lee) announced on January 2nd that it would hold an opening ceremony for the expanded KAIST Center for Contemplative Research (Director Wan Doo Kim) at the Creativity Learning Building on its Daejeon campus on January 3 (Friday).
Established in 2018 with the mission of "integrating meditation and science for the happiness and prosperity of humanity," the KAIST Center for Contemplative Research has been expanding its scope of research into the neuroscience of meditation and training empathetic educators who will lead the field of meditation science in collaboration with the Brain and Cognitive Sciences Department, which was established in 2022.
Supported by the Plato Academy Foundation and with funding from SK Discovery for the facility’s expansion, the center now occupies an extended space on the 5th floor of the Creativity Learning Center. The new facilities include: ▲ Advanced Research Equipment ▲ Meditation Science Laboratories ▲ VR/XR-Based Meditation Experience Rooms ▲ A Large Digital Art Meditation Hall ▲ Personal Meditation Halls.
Particularly, the center plans to conduct next-generation meditation research using cutting-edge technologies such as: ▲ Brain-Computer Interface Technology ▲ Meditation Wearable Devices ▲ Metaverse-Based Meditation Environments.
The opening ceremony, scheduled for the morning of January 3 (Friday), was attended by key figures, including Plato Academy Foundation Chairman Chang-Won Choi, MindLab CEO Professor Seong-Taek Cho, Bosung Group Vice President Byung-Chul Lee, and KAIST President Kwang Hyung Lee.
The event began with a national moment of silence to honor the victims of the recent Jeju Air passenger accident. It included a progress report by the center director, a lecture by Professor Jaeseung Jeong, panel discussions, and more.
Following a tour of the expanded facilities, the center hosted a 20-minute hands-on meditation science session using *Looxid Labs EEG devices for the first 50 participants.
*Looxid Labs EEG Device: A real-time brainwave measurement device developed by KAIST startup Looxid Labs that enables users to experience efficient and AI-powered data-driven meditation science practice (Looxid Labs website: https://looxidlabs.com/).
During the ceremony, Director of the Center for Contemplative Research Wan Doo Kim presented on "The Mission, Vision, and Future of the KAIST Center for Contemplative Research." Yujin Lee, a combined master’s and doctoral researcher from the Brain and Cognitive Sciences Department, shared insights on "The Latest Trends in Meditation Science Research."
A panel discussion and Q&A session on "The Convergence of Meditation and Brain and Cognitive Sciences" followed featuring Professors Jaeseung Jeong, HyungDong Park (Brain and Cognitive Sciences), and Jiyoung Park (Digital Humanities and Social Sciences).
Director Wan Doo Kim commented, “With this expanded opening, we aim to offer advanced meditation programs integrating brain and cognitive sciences and cutting-edge technology not only to KAIST members but also to the general public interested in meditation. We will continue to dedicate ourselves to interdisciplinary research between meditation and science.”
2025.01.03 View 2685 -
KAIST Wins CES 2025 Innovation Award, Showcasing Innovative Technologies
KAIST will showcase innovative technologies at the world’s largest technology fair, the Consumer Electronics Show (CES 2025). In addition, KAIST startups VIRNECT Inc., Standard Energy Inc., A2US Inc., and Panmnesia, Inc. won the 2025 CES Innovation Awards.
< Image 1. 3D-Graphical Profile of CES 2025 KAIST Exhibition Booth >
KAIST (President Kwang-Hyung Lee) announced on the 31st that it will operate a 140㎡ standalone booth at CES Eureka Park, which will be held in Las Vegas, USA from January 7th to 10th next year, to showcase KAIST's innovative technologies to global companies and investors.
KAIST startups VIRNECT, Standard Energy, A2US, and Panmnesia, Inc. won the 2025 CES Innovation Awards. ▴VIRNECT won the Innovation Award in the ‘Industrial Equipment and Machinery’ category for ‘VisionX’, an AI-based smart glass for industrial sites; ▴Standard Energy Co., Ltd. won the Innovation Award in the ‘Smart City’ category for developing the world’s first vanadium-ion battery; ▴A2US won the Innovation Award in the ‘Environment & Energy’ category for its portable air purifier that eliminates bacteria, odors, and fine dust in the air with just water droplets; ▴Panmnesia, Inc. won the Innovation Award in the ‘Computer Peripherals and Accessories’ category for its ‘CXL-based GPU Memory Expansion Kit’ that can drastically reduce the cost of building AI infrastructure.
< Image 2. (From left on the top row) VIRNECT, Standard Energy, (From left on the bottom row) A2US, Panmnesia, Inc. >
This exhibition will feature 15 startups that are standing out in cutting-edge technologies such as artificial intelligence (AI), robotics, mobility, and sustainability. In particular, AI-based deep tech startups in various industries such as logistics, architecture, and medicine will take up half of the total, showcasing the companies’ innovative AI technologies.
Polyphenol Factory Co.,Ltd introduces ‘Grabity’, a hair loss shampoo launched domestically, which applies the patented ingredient ‘LiftMax 308™’ that forms an instantaneous protective layer on the hair during the shampooing process. A real-time demonstration will be held at this exhibition hall so that visitors can experience the effects of the ingredient directly, and plans to enter the global market starting with the launch on Amazon in the US in January 2025.
VIRNECT will present ‘VisionX’, a prototype that won the Innovation Award this time. The product provides a chatbot AI through an AI voice interface, and has a function that allows users to check the status of the equipment in real time through conversations with the AI and receive troubleshooting guidance through voice conversations, so users can experience it directly at the KAIST Hall.
‘Standard Energy’ plans to exhibit ‘Energy Tile’, an indoor ESS that utilizes the world’s first vanadium ion battery (hereinafter referred to as VIB). VIB is absolutely safe from fire and has high installation flexibility, so it can be applied to smart cities and AI data centers.
‘A2US’ is the only company in the world that has hydroxyl radical water production technology, and won the Innovation Award for its first product, an air purifier. In the future, it is expected to be widely commercialized in air and water purification, smart farms, food tech, and semiconductor cleaning using safe and environmentally friendly hydroxyl radical water.
Panmnesia, Inc. won the CES Innovation Award for its GPU memory expansion solution equipped with its CXL 3.1 IP. By connecting a memory expansion device using Panmnesia’s CXL IP, the GPU’s memory capacity can be expanded to the terabyte level. Following the Innovation Award for ‘CXL-equipped AI Accelerator’ at CES 2024 last year, it is the only company to have won the Innovation Award for its AI-oriented CXL solution for two consecutive years.
In addition, technologies from a total of 15 companies will be introduced, including ▴Omelet ▴NEXTWAVE ▴Planby Technologies ▴Cosmo Bee ▴ImpactAI ▴Roen Surgical ▴DIDEN Roboticss ▴Autopedia ▴OAQ ▴HydroXpand ▴BOOKEND ▴Sterri.
On the central stage of the KAIST Hall, KAIST students selected as CES Student Supporters will conduct interviews with participating companies and promote the companies' innovative technologies and solutions. On the 8th, from 5 PM to 7 PM, a KAIST NIGHT event will be held where pre-invited investors and participating companies can network.
Keon Jae Lee, the head of the Institute of Technology Value Creation, said, “Through CES 2025, we will showcase innovative technologies and solutions from startups based on KAIST’s deep science and deep tech, and lead commercialization in cutting-edge technology fields such as AI, robotics, mobility, and environment/energy. KAIST plans to further promote technology commercialization by supporting the growth and marketing of innovative startups through the Institute of Technology Value Creation and by strengthening global networks and expanding cooperation opportunities.”
2024.12.31 View 4548 -
KAIST Develops Foundational Technology to Revert Cancer Cells to Normal Cells
Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, including cancer cells developing resistance and returning, as well as severe side effects from the destruction of healthy cells.
< (From top left) Bio and Brain Engineering PhD candidates Juhee Kim, Jeong-Ryeol Gong, Chun-Kyung Lee, and Hoon-Min Kim posed for a group photo with Professor Kwang-Hyun Cho >
KAIST (represented by President Kwang Hyung Lee) announced on the 20th of December that a research team led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side effects.
The research team focused on the observation that during the oncogenesis process, normal cells regress along their differentiation trajectory. Building on this insight, they developed a technology to create a digital twin of the gene network associated with the differentiation trajectory of normal cells.
< Figure 1. Technology for creating a digital twin of a gene network from single-cell transcriptome data of a normal cell differentiation trajectory. Professor Kwang-Hyun Cho's research team developed a digital twin creation technology that precisely observes the dynamics of gene regulatory relationships during the process of normal cells differentiating along a differentiation trajectory and analyzes the relationships among key genes to build a mathematical model that can be simulated (A-F). In addition, they developed a technology to discover key regulatory factors that control the differentiation trajectory of normal cells by simulating and analyzing this digital twin. >
< Figure 2. Digital twin simulation simulating the differentiation trajectory of normal colon cells. The dynamics of single-cell transcriptome data for the differentiation trajectory of normal colon cells were analyzed (A) and a digital twin of the gene network was developed representing the regulatory relationships of key genes in this differentiation trajectory (B). The simulation results of the digital twin confirm that it readily reproduces the dynamics of single-cell transcriptome data (C, D). >
Through simulation analysis, the team systematically identified master molecular switches that induce normal cell differentiation. When these switches were applied to colon cancer cells, the cancer cells reverted to a normal-like state, a result confirmed through molecular and cellular experiments as well as animal studies.
< Figure 3. Discovery of top-level key control factors that induce differentiation of normal colon cells. By applying control factor discovery technology to the digital twin model, three genes, HDAC2, FOXA2, and MYB, were discovered as key control factors that induce differentiation of normal colon cells (A, B). The results of simulation analysis of the regulatory effects of the discovered control factors through the digital twin confirmed that they could induce complete differentiation of colon cells (C). >
< Figure 4. Verification of the effect of the key control factors discovered using colon cancer cells and animal experiments on the reversibility of colon cancer. The key control factors of the normal colon cell differentiation trajectory discovered through digital twin simulation analysis were applied to actual colon cancer cells and colon cancer mouse animal models to experimentally verify the effect of cancer reversibility. The key control factors significantly reduced the proliferation of three colon cancer cell lines (A), and this was confirmed in the same way in animal models (B-D). >
This research demonstrates that cancer cell reversion can be systematically achieved by analyzing and utilizing the digital twin of the cancer cell gene network, rather than relying on serendipitous discoveries. The findings hold significant promise for developing reversible cancer therapies that can be applied to various types of cancer.
< Figure 5. The change in overall gene expression was confirmed through the regulation of the identified key regulatory factors, which converted the state of colon cancer cells to that of normal colon cells. The transcriptomes of colon cancer tissues and normal colon tissues from more than 400 colon cancer patients were compared with the transcriptomes of colon cancer cell lines and reversible colon cancer cell lines, respectively. The comparison results confirmed that the regulation of the identified key regulatory factors converted all three colon cancer cell lines to a state similar to the transcriptome expression of normal colon tissues. >
Professor Kwang-Hyun Cho remarked, "The fact that cancer cells can be converted back to normal cells is an astonishing phenomenon. This study proves that such reversion can be systematically induced."
He further emphasized, "This research introduces the novel concept of reversible cancer therapy by reverting cancer cells to normal cells. It also develops foundational technology for identifying targets for cancer reversion through the systematic analysis of normal cell differentiation trajectories."
This research included contributions from Jeong-Ryeol Gong, Chun-Kyung Lee, Hoon-Min Kim, Juhee Kim, and Jaeog Jeon, and was published in the online edition of the international journal Advanced Science by Wiley on December 11. (Title: “Control of Cellular Differentiation Trajectories for Cancer Reversion”) DOI: https://doi.org/10.1002/advs.202402132
< Figure 6. Schematic diagram of the research results. Professor Kwang-Hyun Cho's research team developed a source technology to systematically discover key control factors that can induce reversibility of colon cancer cells through a systems biology approach and a digital twin simulation analysis of the differentiation trajectory of normal colon cells, and verified the effects of reversion on actual colon cancer through molecular cell experiments and animal experiments. >
The study was supported by the Ministry of Science and ICT and the National Research Foundation of Korea through the Mid-Career Researcher Program and Basic Research Laboratory Program. The research findings have been transferred to BioRevert Inc., where they will be used for the development of practical cancer reversion therapies.
2024.12.23 View 97929 -
KAIST Proposes a New Way to Circumvent a Long-time Frustration in Neural Computing
The human brain begins learning through spontaneous random activities even before it receives sensory information from the external world. The technology developed by the KAIST research team enables much faster and more accurate learning when exposed to actual data by pre-learning random information in a brain-mimicking artificial neural network, and is expected to be a breakthrough in the development of brain-based artificial intelligence and neuromorphic computing technology in the future.
KAIST (President Kwang-Hyung Lee) announced on the 16th of December that Professor Se-Bum Paik 's research team in the Department of Brain Cognitive Sciences solved the weight transport problem*, a long-standing challenge in neural network learning, and through this, explained the principles that enable resource-efficient learning in biological brain neural networks.
*Weight transport problem: This is the biggest obstacle to the development of artificial intelligence that mimics the biological brain. It is the fundamental reason why large-scale memory and computational work are required in the learning of general artificial neural networks, unlike biological brains.
Over the past several decades, the development of artificial intelligence has been based on error backpropagation learning proposed by Geoffery Hinton, who won the Nobel Prize in Physics this year. However, error backpropagation learning was thought to be impossible in biological brains because it requires the unrealistic assumption that individual neurons must know all the connected information across multiple layers in order to calculate the error signal for learning.
< Figure 1. Illustration depicting the method of random noise training and its effects >
This difficult problem, called the weight transport problem, was raised by Francis Crick, who won the Nobel Prize in Physiology or Medicine for the discovery of the structure of DNA, after the error backpropagation learning was proposed by Hinton in 1986. Since then, it has been considered the reason why the operating principles of natural neural networks and artificial neural networks will forever be fundamentally different.
At the borderline of artificial intelligence and neuroscience, researchers including Hinton have continued to attempt to create biologically plausible models that can implement the learning principles of the brain by solving the weight transport problem.
In 2016, a joint research team from Oxford University and DeepMind in the UK first proposed the concept of error backpropagation learning being possible without weight transport, drawing attention from the academic world. However, biologically plausible error backpropagation learning without weight transport was inefficient, with slow learning speeds and low accuracy, making it difficult to apply in reality.
KAIST research team noted that the biological brain begins learning through internal spontaneous random neural activity even before experiencing external sensory experiences. To mimic this, the research team pre-trained a biologically plausible neural network without weight transport with meaningless random information (random noise).
As a result, they showed that the symmetry of the forward and backward neural cell connections of the neural network, which is an essential condition for error backpropagation learning, can be created. In other words, learning without weight transport is possible through random pre-training.
< Figure 2. Illustration depicting the meta-learning effect of random noise training >
The research team revealed that learning random information before learning actual data has the property of meta-learning, which is ‘learning how to learn.’ It was shown that neural networks that pre-learned random noise perform much faster and more accurate learning when exposed to actual data, and can achieve high learning efficiency without weight transport.
< Figure 3. Illustration depicting research on understanding the brain's operating principles through artificial neural networks >
Professor Se-Bum Paik said, “It breaks the conventional understanding of existing machine learning that only data learning is important, and provides a new perspective that focuses on the neuroscience principles of creating appropriate conditions before learning,” and added, “It is significant in that it solves important problems in artificial neural network learning through clues from developmental neuroscience, and at the same time provides insight into the brain’s learning principles through artificial neural network models.”
This study, in which Jeonghwan Cheon, a Master’s candidate of KAIST Department of Brain and Cognitive Sciences participated as the first author and Professor Sang Wan Lee of the same department as a co-author, was presented at the 38th Neural Information Processing Systems (NeurIPS), the world's top artificial intelligence conference, on December 14th in Vancouver, Canada. (Paper title: Pretraining with random noise for fast and robust learning without weight transport)
This study was conducted with the support of the National Research Foundation of Korea's Basic Research Program in Science and Engineering, the Information and Communications Technology Planning and Evaluation Institute's Talent Development Program, and the KAIST Singularity Professor Program.
2024.12.16 View 5637 -
KAIST Awarded Presidential Commendation for Contributions in Software Industry
- At the “25th Software Industry Day” celebration held in the afternoon on Monday, December 2nd, 2024 at Yangjae L Tower in Seoul
- KAIST was awarded the “Presidential Commendation” for its contributions for the advancement of the Software Industry in the Group Category
- Korea’s first AI master’s and doctoral degree program opened at KAIST Kim Jaechul Graduate School of AI
- Focus on training non-major developers through SW Officer Training Academy "Jungle", Machine Learning Engineer Bootcamp, etc., talents who can integrate development and collaboration, and advanced talents in the latest AI technologies.
- Professor Minjoon Seo of KAIST Kim Jaechul Graduate School of AI received Prime Minister’s Commendation for his contributions for the advancement of the software industry.
< Photo 1. Professor Kyung-soo Kim, the Senior Vice President for Planning and Budget (second from the left) and the Manager of Planning Team, Mr. Sunghoon Jung, stand at the stage after receiving the Presidential Commendation as KAIST was selected as one of the groups that contributed to the advancement of the software industry at the "25th Software Industry Day" celebration. >
“KAIST has been leading the way in achieving the grand goal of fostering 1 million AI talents in Korea by services that pan from providing various educational opportunities, from developing the capabilities of experts with no computer science specialty to fostering advanced professionals. I would like to thank all members of KAIST community who worked hard to achieve the great feat of receiving the Presidential Commendations.” (KAIST President Kwang Hyung Lee)
KAIST (President Kwang Hyung Lee) announced on December 3rd that it was selected as a group that contributed to the advancement of the software industry at the “2024 Software Industry Day” celebration held at the Yangjae El Tower in Seoul on the 2nd of December and received a presidential commendation.
The “Software Industry Day”, hosted by the Ministry of Science and ICT and organized by the National IT Industry Promotion Agency and the Korea Software Industry Association, is an event designed to promote the status of software industry workers in Korea and to honor their achievements.
Every year, those who have made significant contributions to policy development, human resource development, and export growth for industry revitalization are selected and awarded the ‘Software Industry Development Contribution Award.’
KAIST was recognized for its contribution to developing a demand-based, industrial field-centric curriculum and fostering non-major developers and convergence talents with the goal of expanding software value and fostering excellent human resources.
< Photo 2. Senior Vice President for Planning and Budget Kyung-soo Kim receiving the commendation as the representative of KAIST >
Specifically, it first opened the SW Officer Training Academy "Jungle" to foster convergent program developers equipped with the abilities to handle both the computer coding and human interactions for collaborations. This is a non-degree program that provides intensive study and assignments for 5 months for graduates and intellectuals without prior knowledge of computer science.
KAIST Kim Jaechul Graduate School of AI opened and operated Korea’s first master's and doctoral degree program in the field of artificial intelligence. In addition, it planned a “Machine Learning Engineers’ Boot Camp” and conducted lectures and practical training for a total of 16 weeks on the latest AI technologies such as deep learning basics and large language models. It aims to strengthen the practical capabilities of start-up companies while lowering the threshold for companies to introduce AI technology.
Also, KAIST was selected to participate in the 1st and 2nd stages of the Software-centered University Project and has been taking part in the project since 2016. Through this, it was highly evaluated for promoting curriculum based on latest technology, an autonomous system where students directly select integrated education, and expansion of internships.
< Photo 3. Professor Minjoon Seo of Kim Jaechul Graduate School of AI, who received the Prime Minister's Commendation for his contribution to the advancement of the software industry on the same day >
At the awards ceremony that day, Professor Minjoon Seo of KAIST Kim Jaechul Graduate School of AI also received the Prime Minister's Commendation for his contribution to the advancement of the software industry. Professor Seo was recognized for his leading research achievements in the fields of AI and natural language processing by publishing 28 papers in top international AI conferences over the past four years.
At the same time, he was noted for his contributions to enhancing the originality and innovation of language model research, such as △knowledge encoding, △knowledge access and utilization, and △high-dimensional inference performance, and for demonstrating leadership in the international academic community.
President Kwang Hyung Lee of KAIST stated, “Our university will continue to do its best to foster software talents with global competitiveness through continuous development of cutting-edge curriculum and innovative degree systems.”
2024.12.03 View 4503 -
KAIST Professor Uichin Lee Receives Distinguished Paper Award from ACM
< Photo. Professor Uichin Lee (left) receiving the award >
KAIST (President Kwang Hyung Lee) announced on the 25th of October that Professor Uichin Lee’s research team from the School of Computing received the Distinguished Paper Award at the International Joint Conference on Pervasive and Ubiquitous Computing and International Symposium on Wearable Computing (Ubicomp / ISWC) hosted by the Association for Computing Machinery (ACM) in Melbourne, Australia on October 8.
The ACM Ubiquitous Computing Conference is the most prestigious international conference where leading universities and global companies from around the world present the latest research results on ubiquitous computing and wearable technologies in the field of human-computer interaction (HCI).
The main conference program is composed of invited papers published in the Proceedings of the ACM (PACM) on Interactive, Mobile, Wearable and Ubiquitous Technologies (IMWUT), which covers the latest research in the field of ubiquitous and wearable computing.
The Distinguished Paper Award Selection Committee selected eight papers among 205 papers published in Vol. 7 of the ACM Proceedings (PACM IMWUT) that made outstanding and exemplary contributions to the research community. The committee consists of 16 prominent experts who are current and former members of the journal's editorial board which made the selection after a rigorous review of all papers for a period that stretched over a month.
< Figure 1. BeActive mobile app to promote physical activity to form active lifestyle habits >
The research that won the Distinguished Paper Award was conducted by Dr. Junyoung Park, a graduate of the KAIST Graduate School of Data Science, as the 1st author, and was titled “Understanding Disengagement in Just-in-Time Mobile Health Interventions”
Professor Uichin Lee’s research team explored user engagement of ‘Just-in-Time Mobile Health Interventions’ that actively provide interventions in opportune situations by utilizing sensor data collected from health management apps, based on the premise that these apps are aptly in use to ensure effectiveness.
< Figure 2. Traditional user-requested digital behavior change intervention (DBCI) delivery (Pull) vs. Automatic transmission (Push) for Just-in-Time (JIT) mobile DBCI using smartphone sensing technologies >
The research team conducted a systematic analysis of user disengagement or the decline in user engagement in digital behavior change interventions. They developed the BeActive system, an app that promotes physical activities designed to help forming active lifestyle habits, and systematically analyzed the effects of users’ self-control ability and boredom-proneness on compliance with behavioral interventions over time.
The results of an 8-week field trial revealed that even if just-in-time interventions are provided according to the user’s situation, it is impossible to avoid a decline in participation. However, for users with high self-control and low boredom tendency, the compliance with just-in-time interventions delivered through the app was significantly higher than that of users in other groups.
In particular, users with high boredom proneness easily got tired of the repeated push interventions, and their compliance with the app decreased more quickly than in other groups.
< Figure 3. Just-in-time Mobile Health Intervention: a demonstrative case of the BeActive system: When a user is identified to be sitting for more than 50 mins, an automatic push notification is sent to recommend a short active break to complete for reward points. >
Professor Uichin Lee explained, “As the first study on user engagement in digital therapeutics and wellness services utilizing mobile just-in-time health interventions, this research provides a foundation for exploring ways to empower user engagement.” He further added, “By leveraging large language models (LLMs) and comprehensive context-aware technologies, it will be possible to develop user-centered AI technologies that can significantly boost engagement."
< Figure 4. A conceptual illustration of user engagement in digital health apps. Engagement in digital health apps consists of (1) engagement in using digital health apps and (2) engagement in behavioral interventions provided by digital health apps, i.e., compliance with behavioral interventions. Repeated adherences to behavioral interventions recommended by digital health apps can help achieve the distal health goals. >
This study was conducted with the support of the 2021 Biomedical Technology Development Program and the 2022 Basic Research and Development Program of the National Research Foundation of Korea funded by the Ministry of Science and ICT.
< Figure 5. A conceptual illustration of user disengagement and engagement of digital behavior change intervention (DBCI) apps. In general, user engagement of digital health intervention apps consists of two components: engagement in digital health apps and engagement in behavioral interventions recommended by such apps (known as behavioral compliance or intervention adherence). The distinctive stages of user can be divided into adoption, abandonment, and attrition. >
< Figure 6. Trends of changes in frequency of app usage and adherence to behavioral intervention over 8 weeks, ● SC: Self-Control Ability (High-SC: user group with high self-control, Low-SC: user group with low self-control) ● BD: Boredom-Proneness (High-BD: user group with high boredom-proneness, Low-BD: user group with low boredom-proneness). The app usage frequencies were declined over time, but the adherence rates of those participants with High-SC and Low-BD were significantly higher than other groups. >
2024.10.25 View 5916 -
KAIST Develops a Fire-risk Free Self-Powered Hydrogen Production System
KAIST researchers have developed a new hydrogen production system that overcomes the current limitations of green hydrogen production. By using a water-splitting system with an aqueous electrolyte, this system is expected to block fire risks and enable stable hydrogen production.
KAIST (represented by President Kwang Hyung Lee) announced on the 22nd of October that a research team led by Professor Jeung Ku Kang from the Department of Materials Science and Engineering developed a self-powered hydrogen production system based on a high-performance zinc-air battery*.
*Zinc-air battery: A primary battery that absorbs oxygen from the air and uses it as an oxidant. Its advantage is long life, but its low electromotive force is a disadvantage.
Hydrogen (H₂) is a key raw material for synthesizing high-value-added substances, and it is gaining attention as a clean fuel with an energy density (142 MJ/kg) more than three times higher than traditional fossil fuels (gasoline, diesel, etc.). However, most current hydrogen production methods impose environmental burden as they emit carbon dioxide (CO₂).
While green hydrogen can be produced by splitting water using renewable energy sources such as solar cells and wind power, these sources are subject to irregular power generation due to weather and temperature fluctuations, leading to low water-splitting efficiency.
To overcome this, air batteries that can emit sufficient voltage (greater than 1.23V) for water splitting have been gaining attention. However, achieving sufficient capacity requires expensive precious metal catalysts and the performance of the catalyst materials becomes significantly degraded during prolonged charge and discharge cycles. Thus, it is essential to develop catalysts that are effective for the water-splitting reactions (oxygen and hydrogen evolution) and materials that can stabilize the repeated charge and discharge reactions (oxygen reduction and evolution) in zinc-air battery electrodes.
In response, Professor Kang's research team proposed a method to synthesize a non-precious metal catalyst material (G-SHELL) that is effective for three different catalytic reactions (oxygen evolution, hydrogen evolution, and oxygen reduction) by growing nano-sized, metal-organic frameworks on graphene oxide.
The team incorporated the developed catalyst material into the air cathode of a zinc-air battery, confirming that it achieved approximately five times higher energy density (797Wh/kg), high power characteristics (275.8mW/cm²), and long-term stability even under repeated charge and discharge conditions compared to conventional batteries.
Additionally, the zinc-air battery, which operates using an aqueous electrolyte, is safe from fire risks. It is expected that this system can be applied as a next-generation energy storage device when linked with water electrolysis systems, offering an environmentally friendly method for hydrogen production.
< Figure 1. Illustrations of a trifunctional graphene-sandwiched heterojunction-embedded layered lattice (G-SHELL) structure. Schematic representation of a) synthesis procedures of G-SHELL from a zeolitic imidazole framework, b) hollow core-layered shell structure with trifunctional sites for oxygen reduction evolution (ORR), oxygen evolution reaction (OER), and hydrogen evolution reaction (HER), and c) heterojunctions, eterojunction-induced internal electric fields, and the corresponding band structure. >
Professor Kang explained, "By developing a catalyst material with high activity and durability for three different electrochemical catalytic reactions at low temperatures using simple methods, the self-powered hydrogen production system we implemented based on zinc-air batteries presents a new breakthrough to overcome the current limitations of green hydrogen production."
<Figure 2. Electrochemical performance of a ZAB-driven water-splitting cell with G-SHELL. Diagram of a self-driven water-splitting cell integrated by combining a ZAB with an alkaline water electrolyzer.>
PhD candidate Dong Won Kim and Jihoon Kim, a master's student in the Department of Materials Science and Engineering at KAIST, were co-first authors of this research, which was published in the international journal Advanced Science on September 17th in the multidisciplinary field of materials science. (Paper Title: “Trifunctional Graphene-Sandwiched Heterojunction-Embedded Layered Lattice Electrocatalyst for High Performance in Zn-Air Battery-Driven Water Splitting”)
This research was supported by the Nano and Material Technology Development Program of the Ministry of Science and ICT and the National Research Foundation of Korea’s Future Technology Research Laboratory.
2024.10.22 View 4594 -
KAIST Employs Image-recognition AI to Determine Battery Composition and Conditions
An international collaborative research team has developed an image recognition technology that can accurately determine the elemental composition and the number of charge and discharge cycles of a battery by examining only its surface morphology using AI learning.
KAIST (President Kwang-Hyung Lee) announced on July 2nd that Professor Seungbum Hong from the Department of Materials Science and Engineering, in collaboration with the Electronics and Telecommunications Research Institute (ETRI) and Drexel University in the United States, has developed a method to predict the major elemental composition and charge-discharge state of NCM cathode materials with 99.6% accuracy using convolutional neural networks (CNN)*.
*Convolutional Neural Network (CNN): A type of multi-layer, feed-forward, artificial neural network used for analyzing visual images.
The research team noted that while scanning electron microscopy (SEM) is used in semiconductor manufacturing to inspect wafer defects, it is rarely used in battery inspections. SEM is used for batteries to analyze the size of particles only at research sites, and reliability is predicted from the broken particles and the shape of the breakage in the case of deteriorated battery materials.
The research team decided that it would be groundbreaking if an automated SEM can be used in the process of battery production, just like in the semiconductor manufacturing, to inspect the surface of the cathode material to determine whether it was synthesized according to the desired composition and that the lifespan would be reliable, thereby reducing the defect rate.
< Figure 1. Example images of true cases and their grad-CAM overlays from the best trained network. >
The researchers trained a CNN-based AI applicable to autonomous vehicles to learn the surface images of battery materials, enabling it to predict the major elemental composition and charge-discharge cycle states of the cathode materials. They found that while the method could accurately predict the composition of materials with additives, it had lower accuracy for predicting charge-discharge states. The team plans to further train the AI with various battery material morphologies produced through different processes and ultimately use it for inspecting the compositional uniformity and predicting the lifespan of next-generation batteries.
Professor Joshua C. Agar, one of the collaborating researchers of the project from the Department of Mechanical Engineering and Mechanics of Drexel University, said, "In the future, artificial intelligence is expected to be applied not only to battery materials but also to various dynamic processes in functional materials synthesis, clean energy generation in fusion, and understanding foundations of particles and the universe."
Professor Seungbum Hong from KAIST, who led the research, stated, "This research is significant as it is the first in the world to develop an AI-based methodology that can quickly and accurately predict the major elemental composition and the state of the battery from the structural data of micron-scale SEM images. The methodology developed in this study for identifying the composition and state of battery materials based on microscopic images is expected to play a crucial role in improving the performance and quality of battery materials in the future."
< Figure 2. Accuracies of CNN Model predictions on SEM images of NCM cathode materials with additives under various conditions. >
This research was conducted by KAIST’s Materials Science and Engineering Department graduates Dr. Jimin Oh and Dr. Jiwon Yeom, the co-first authors, in collaboration with Professor Josh Agar and Dr. Kwang Man Kim from ETRI. It was supported by the National Research Foundation of Korea, the KAIST Global Singularity project, and international collaboration with the US research team. The results were published in the international journal npj Computational Materials on May 4. (Paper Title: “Composition and state prediction of lithium-ion cathode via convolutional neural network trained on scanning electron microscopy images”)
2024.07.02 View 5533 -
KAIST begins full-scale cooperation with Taiwan’s Formosa Group
< (From left) Senior Vice President for Planning and Budget Kyung-Soo Kim, and Professor Minee Choi of the Department of Brain and Cognitive Sciences of KAIST along with Chairman of Formosa Group Sandy Wang and KAIST President Kwang-Hyung Lee, and Dean Daesoo Kim of KAIST College of Life Science and Bioengineering >
KAIST is pursuing cooperation in the fields of advanced biotechnology and eco-friendly energy with Formosa Plastics Group, one of Taiwan's three largest companies.
To this end, Chairman Sandy Wang, a member of Formosa Group's standing committee and leader of the group's bio and eco-friendly energy sector, will visit KAIST on the 13th of this month. This is the first time that the owner of Formosa Group has made an official visit to KAIST.
Cooperation between the two institutions began last March when our university signed a memorandum of understanding on comprehensive exchange and cooperation with Ming Chi University of Science and Technology (明志科技大學), Chang Gung University(長庚大學), and Chang Gung Memorial Hospital(長庚記念醫院), three of many institutions established and supported by Formosa Group.
Based on this, Chairman Sandy Wang, who visits our university to promote more exchanges and cooperation, talked about ‘the education of children and corporate social return and practice of his father, Chairman Yung-Ching Wang,’ through a special lecture for the school leadership as a part of the Monthly Lecture on KAIST’s Leadership Innovation Day.
She then visited KAIST's research and engineering facilities related to Taiwan's future industries, such as advanced biotechnology and eco-friendly energy, and discussed global industry-academic cooperation plans. In the future, the two organizations plan to appoint adjunct professors and promote practical global cooperation, including joint student guidance and research cooperation. We plan to pursue effective mid- to long-term cooperation, such as conducting battery application research with the KAIST Next-Generation ESS Research Center and opening a graduate program specialized in stem cell and gene editing technology in connection with Chang Gung University and Chang Gung Memorial Hospital. The newly established cooperative relationship will also promote Formosa Group's investment and cooperation with KAIST's outstanding venture companies related to bio and eco-friendly energy to lay the foundation for innovative industrial cooperation between Taiwan and Korea.
President Kwang-Hyung Lee said, “The Formosa Group has a global network, so we regard it to be a key partner that will position KAIST’s bio and engineering technology in the global stages.” He also said, “With Chairman Sandy Wang’s visit, Taiwan is emerging as a global economic powerhouse,” and added, “We expect to continue our close cooperative relationship with the company.”
Formosa Group is a company founded by the late Chairman Yung-Ching Wang, the father of Chairman Sandy Wang. As the world's No. 1 plastic PVC producer, it is leading the core industries of Taiwan's economy, including semiconductors, steel, heavy industry, bio, and batteries. Chairman Yung-Ching Wang was respected by the Taiwanese people by setting an example of returning his wealth to society under the belief that the companies and assets he built ‘belonged to the people.’ Chang Gung University, Chang Gung Memorial Hospital, and Ming Chi University of Technology, which are pursuing cooperation with our university, were also established as part of the social contribution promoted by Chairman Yung-Ching Wang and are receiving financial support from Formosa Group.
2024.05.09 View 5215 -
Dr. Bong-Joon Jung Elected as Interim President of KAIST U.S. Alumni Association
On April 29th, 2024, the Office of Global Initiative at KAIST, led by Vice President Man-Sung Yim, successfully conducted the election for the interim president of the KAIST U.S. Alumni Association. The authority to organize and operate the election was delegated by the KAIST U.S. Alumni Interim President Selection Committee Foundation, consisting of Je Woo Kim, Director of KAIST U.S. Foundation; Terri Kim, Director of KAIST U.S. Foundation; and Myungjin Yim, President of the KAIST Silicon Valley Alumni Association.
The election was announced during the KAIST Online U.S. Alumni Event held on December 8th, 2023, with the aim of establishing interim executive principles for six months and ultimately forming the official executive body of the KAIST U.S. Alumni Association.
The election was conducted according to the requirements set by the KAIST U.S. Alumni Interim President Selection Committee Foundation, which stated that "if there is a single candidate, they will be elected if they receive more than half of the votes from participating voters." The voting period lasted from April 13th (Monday) to April 24th (Friday) and was specifically directed towards KAIST alumni living in the Americas.
All 50 eligible voters participated in the election, unanimously supporting Dr. Bong-Joon Jung (Ph.D., admitted in 1993, Department of Electrical Engineering) with a 100% approval rate as the interim president of the KAIST U.S. Alumni Association. Dr. Bong-Joon Jung currently serves as the Senior Technology Analyst and Partner at Ambex Venture Group and previously served as the President of the KAIST Silicon Valley Alumni Association. Dr. Jung expressed his intention to strengthen connections with KAIST alumni in the United States and contribute to the establishment of the U.S. alumni association as the interim president.
< Photo. Newly elected president of interim KAIST U.S. Alumni Association, Dr. Bong-Joon Jung. >
Man-Sung Yim, Vice President of the International Office, congratulated Dr. Bong-Joon Jung on his election and pledged continuous support for the activities of the interim KAIST U.S. Alumni Association, led by alumni. He stated, "The election of the interim president of the KAIST U.S. Alumni Association marks the beginning of active engagement not only from alumni associations in various regions but also from alumni across the Americas, reflecting sustained interest in their alma mater."
2024.04.29 View 4410 -
A Korean research team develops a new clinical candidate for fatty liver disease
A team of Korean researchers have succeeded in developing a new drug candidate for the treatment of non-alcoholic fatty liver disease (NAFLD) acting on peripheral tissues. To date, there has not been an optimal treatment for non-alcoholic steatohepatitis (NASH), and this discovery is expected to set the grounds for the development of new drugs that can safely suppress both liver fat accumulation and liver fibrosis at the same time.
A joint research team led by Professor Jin Hee Ahn from Gwangju Institute of Science and Technology (GIST) and Professor Hail Kim from the KAIST Graduate School of Medical Science and Engineering developed a new chemical that can suppress disease-specific protein (HTR2A) through years of basic research. The team also revealed to have verified its efficacy and safety through preclinical tests (animal tests) at JD Bioscience Inc., a start-up company founded by Professor Ahn.
Although NAFLD has a prevalence rate as high as 20-30%, and about 5% of the global adult population suffers from NASH, there are no commercial drugs targeting them to date. NAFLD is a chronic disease that starts from the fatty liver and progresses into steatohepatitis, fibrosis, cirrhosis, and liver cancer. The mortality rate of patients increases with accompanied cardiovascular diseases and liver-related complications, and appropriate treatment in the early stage is hence necessary.
< Figure 1. Strategy and history of 5HT2A antagonists. Library and rational design for the development of compound 11c as a potent 5HT2A antagonist. Previous research efforts were discontinued due to limited oral absorption and safety. A therapeutic candidate to overcome this problem was identified and phase 1 clinical trials are currently in progress. >
The new synthetic chemical developed by the joint GIST-KAIST research is an innovative drug candidate that shows therapeutic effects on NASH based on a dual action mechanism that inhibits the accumulation of fat in the liver and liver fibrosis by suppressing the serotonin receptor protein 5HT2A.
The research team confirmed its therapeutic effects in animal models for NAFLD and NASH, in which hepatic steatosis and liver fibrosis* caused by fat accumulation in the liver were suppressed simultaneously by 50-70%.
*fibrosis: stiffening of parts of the liver, also used as a major indicator to track the prognosis of steatosis
The research team explained that the material was designed with optimal polarity and lipid affinity to minimize its permeability across the blood-brain barrier. It therefore does not affect the brain, and causes little side effects in the central nervous system (CNS) such as depression and suicidal ideations, while demonstrating excellent inhibition on its target protein present in tissues outside brain (IC50* = 14 nM). The team also demonstrated its superior efficacy in improving liver fibrosis when compared to similar drugs in the phase 3 clinical trial.
*IC50 (half maximal inhibitory concentration): the concentration at which a chemical suppresses 50% of a particular biological function
< Figure 2. GM-60106 (11c)'s effect on obesity: When GM-60106 was administered to an obese animal model (mice) for 2 months, body weight, body fat mass, and blood sugar were significantly reduced (a-d). In addition, the steatohepatitis level (NAFLD Activity Score) and the expression of genes of the treated mice involved in adipogenesis along with blood/liver fat decreased (e-h) >
Based on the pharmacological data obtained through preclinical trials, the team evaluated the effects of the drug on 88 healthy adults as part of their phase 1 clinical trial, where the side effects and the safe dosage of a drug are tested against healthy adults. Results showed no serious side effects and a good level of drug safety.
In addition, a preliminary efficacy evaluation on eight adults with steatohepatitis is currently underway.
Professor Jin Hee Ahn said, “The aim of this research is to develop a treatment for NASH with little side effects and guaranteed safety by developing a new target. The developed chemical is currently going through phase 1 of the global clinical trial in Australia through JD Bioscience Inc., a bio venture company for innovative drug development.” he added, “The candidate material the research team is currently developing shows not only a high level of safety and preventative effects by suppressing fat accumulation in the liver, but also a direct therapeutic effect on liver fibrosis. This is a strength that distinguishes our material from other competing drugs.”
< Figure 3. Efficacy of GM-60106 (11c) on liver fibrosis: When GM-60106 was administered to a steatohepatitis model (mice) for 3 months, the expression of genes associated with tissue fibrosis was significantly reduced (b-c). As a result of a detailed analysis of the tissues of the animal model, it was confirmed that the rate of tissue fibrosis was reduced and the expression rate of genes related to tissue fibrosis and inflammation was also significantly reduced (e-h). >
Professor Hail Kim from KAIST said, “Until now, this disease did not have a method of treatment other than weight control, and there has been no attempt to develop a drug that can be used for non-obese patients.” He added, “Through this research, we look forward to the development of various treatment techniques targeting a range of metabolic diseases including NASH that do not affect the weight of the patient.”
This study, conducted together by the research teams led by Professor Ahn from GIST and Professor Kim from KAIST, as well as the research team from JD Bioscience Inc., was supported by the Ministry of Science and ICT, and the National New Drug Development Project. The results of this research were published by Nature Communications on January 20.
The team also presented the results of their clinical study on the candidate material coded GM-60106 targeting metabolic abnormality-related MASH* at NASH-TAG Conference 2024, which was held in Utah for three days starting on January 4, which was selected as an excellent abstract.
*MASH (Metabolic Dysfunction-Associated Steatohepatitis): new replacement term for NASH
2024.02.21 View 8259